Skip to main content
. 2022 May;15(5):631–634. doi: 10.25122/jml-2021-0380

Table 1.

Clinical investigations of research participants.

Parameters Total (n=198) P-value*
Sex Male 79 (39.9%) 0.531
Female 119 (60.1%) 0.519
Age 56.04±15.25 0.801
Favipiravir 42 (21.2%) 0.843
Remdesevier 42 (21.2%) 0.072
Corona positive PCR 138 (69.7%) ≤0.01
Hair loss No 150 (75.8%) 0.0512
Yes 48 (24.2%) 0.145
*

– p˂0.05.